Scientists at the University of California San Diego School of Medicine have been awarded a contract of up to $11.312 million from the Defense Advanced Research Projects Agency (DARPA) to pursue a research project aimed at developing optimized red blood cells that can temporarily boost human performance and health.
The three-year project seeks to create “smart” red blood cells capable of temporarily enhancing oxygen delivery in the body and will explore the potential of this technology to improve performance in military personnel, who are frequently placed in unforgiving environments where maintaining peak performance is essential to survival.
“This DARPA award is a testament to UC San Diego’s commitment to advancing cutting-edge research and innovation,” said John Carethers, MD, vice chancellor for health sciences at UC San Diego. “DARPA follows a ‘moonshot’ model, where the goal is nearly impossible but successful projects can be highly impactful, and…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
